Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test

Michael A Campos, Andrew Quartin, Eliana Mendes, Alexandre Abreu, Samuel Gurevich, Luis Echarte, Tanira Ferreira, Timothy Cleary, Elena Hollender, David Ashkin

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Rationale: Serial smear analysis to guide respiratory isolation (RI) of patients with suspected tuberculosis (TB), the majorityofwhom will be found not to have TB, leads to expensive and unnecessary isolation, and may potentially result in decreased vigilance of subjects with respiratory compromise. Objectives: To compare the performance of a single first-sputum, Mycobacterium tuberculosis-specific nucleic acid amplification (NAA) test with three sputum smears for assessing the need for RI. Methods: Prospective evaluation of 493 patients with suspected TB (74% HIV positive) admitted to RI in a major county hospital in the United States, who had at least three sputum smears and material available from the first sample for additional NAA testing. Measurementsand Main Results: Accuracy of the first sputum NAA result and serial smears for identifying patients with potentially infectious TB who truly require RI was determined. Forty-six patients (9.3%) had TB confirmed by culture. First-sputum NAA test detected all patients with TB who had a positive smear (n = 35), even when the first of the three specimens was smear negative. In addition, when compared with serial smears, the first-sputum NAA had a higher sensitivity (0.87; 95% confidence interval [CI], 0.74-0.95) and specificity (1.0) in the detection of subjects with positive M. tuberculosis cultures (smear sensitivity, 0.76; 95% CI, 0.61-0.87; and specificity, 0.96; 95% CI, 0.94-0.98). Conclusions: A single first-sputum NAA testing can rapidly and accurately identify the subset of patients with suspected TB who require RI according to serial sputum smears. Its potential use to shorten RI time does not preclude the need to obtain subsequent specimens for culture.

Original languageEnglish
Pages (from-to)300-305
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume178
Issue number3
DOIs
StatePublished - Aug 1 2008

Fingerprint

Nucleic Acid Amplification Techniques
Sputum
Tuberculosis
Nucleic Acids
Confidence Intervals
Mycobacterium tuberculosis
Patient Isolation
County Hospitals
HIV

Keywords

  • Diagnostic test
  • Nucleic acid amplification
  • Sensitivity
  • Specificity
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. / Campos, Michael A; Quartin, Andrew; Mendes, Eliana; Abreu, Alexandre; Gurevich, Samuel; Echarte, Luis; Ferreira, Tanira; Cleary, Timothy; Hollender, Elena; Ashkin, David.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 178, No. 3, 01.08.2008, p. 300-305.

Research output: Contribution to journalArticle

Campos, Michael A ; Quartin, Andrew ; Mendes, Eliana ; Abreu, Alexandre ; Gurevich, Samuel ; Echarte, Luis ; Ferreira, Tanira ; Cleary, Timothy ; Hollender, Elena ; Ashkin, David. / Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. In: American Journal of Respiratory and Critical Care Medicine. 2008 ; Vol. 178, No. 3. pp. 300-305.
@article{a995c50b929d46d795983fbb44375542,
title = "Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test",
abstract = "Rationale: Serial smear analysis to guide respiratory isolation (RI) of patients with suspected tuberculosis (TB), the majorityofwhom will be found not to have TB, leads to expensive and unnecessary isolation, and may potentially result in decreased vigilance of subjects with respiratory compromise. Objectives: To compare the performance of a single first-sputum, Mycobacterium tuberculosis-specific nucleic acid amplification (NAA) test with three sputum smears for assessing the need for RI. Methods: Prospective evaluation of 493 patients with suspected TB (74{\%} HIV positive) admitted to RI in a major county hospital in the United States, who had at least three sputum smears and material available from the first sample for additional NAA testing. Measurementsand Main Results: Accuracy of the first sputum NAA result and serial smears for identifying patients with potentially infectious TB who truly require RI was determined. Forty-six patients (9.3{\%}) had TB confirmed by culture. First-sputum NAA test detected all patients with TB who had a positive smear (n = 35), even when the first of the three specimens was smear negative. In addition, when compared with serial smears, the first-sputum NAA had a higher sensitivity (0.87; 95{\%} confidence interval [CI], 0.74-0.95) and specificity (1.0) in the detection of subjects with positive M. tuberculosis cultures (smear sensitivity, 0.76; 95{\%} CI, 0.61-0.87; and specificity, 0.96; 95{\%} CI, 0.94-0.98). Conclusions: A single first-sputum NAA testing can rapidly and accurately identify the subset of patients with suspected TB who require RI according to serial sputum smears. Its potential use to shorten RI time does not preclude the need to obtain subsequent specimens for culture.",
keywords = "Diagnostic test, Nucleic acid amplification, Sensitivity, Specificity, Tuberculosis",
author = "Campos, {Michael A} and Andrew Quartin and Eliana Mendes and Alexandre Abreu and Samuel Gurevich and Luis Echarte and Tanira Ferreira and Timothy Cleary and Elena Hollender and David Ashkin",
year = "2008",
month = "8",
day = "1",
doi = "10.1164/rccm.200803-381OC",
language = "English",
volume = "178",
pages = "300--305",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test

AU - Campos, Michael A

AU - Quartin, Andrew

AU - Mendes, Eliana

AU - Abreu, Alexandre

AU - Gurevich, Samuel

AU - Echarte, Luis

AU - Ferreira, Tanira

AU - Cleary, Timothy

AU - Hollender, Elena

AU - Ashkin, David

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Rationale: Serial smear analysis to guide respiratory isolation (RI) of patients with suspected tuberculosis (TB), the majorityofwhom will be found not to have TB, leads to expensive and unnecessary isolation, and may potentially result in decreased vigilance of subjects with respiratory compromise. Objectives: To compare the performance of a single first-sputum, Mycobacterium tuberculosis-specific nucleic acid amplification (NAA) test with three sputum smears for assessing the need for RI. Methods: Prospective evaluation of 493 patients with suspected TB (74% HIV positive) admitted to RI in a major county hospital in the United States, who had at least three sputum smears and material available from the first sample for additional NAA testing. Measurementsand Main Results: Accuracy of the first sputum NAA result and serial smears for identifying patients with potentially infectious TB who truly require RI was determined. Forty-six patients (9.3%) had TB confirmed by culture. First-sputum NAA test detected all patients with TB who had a positive smear (n = 35), even when the first of the three specimens was smear negative. In addition, when compared with serial smears, the first-sputum NAA had a higher sensitivity (0.87; 95% confidence interval [CI], 0.74-0.95) and specificity (1.0) in the detection of subjects with positive M. tuberculosis cultures (smear sensitivity, 0.76; 95% CI, 0.61-0.87; and specificity, 0.96; 95% CI, 0.94-0.98). Conclusions: A single first-sputum NAA testing can rapidly and accurately identify the subset of patients with suspected TB who require RI according to serial sputum smears. Its potential use to shorten RI time does not preclude the need to obtain subsequent specimens for culture.

AB - Rationale: Serial smear analysis to guide respiratory isolation (RI) of patients with suspected tuberculosis (TB), the majorityofwhom will be found not to have TB, leads to expensive and unnecessary isolation, and may potentially result in decreased vigilance of subjects with respiratory compromise. Objectives: To compare the performance of a single first-sputum, Mycobacterium tuberculosis-specific nucleic acid amplification (NAA) test with three sputum smears for assessing the need for RI. Methods: Prospective evaluation of 493 patients with suspected TB (74% HIV positive) admitted to RI in a major county hospital in the United States, who had at least three sputum smears and material available from the first sample for additional NAA testing. Measurementsand Main Results: Accuracy of the first sputum NAA result and serial smears for identifying patients with potentially infectious TB who truly require RI was determined. Forty-six patients (9.3%) had TB confirmed by culture. First-sputum NAA test detected all patients with TB who had a positive smear (n = 35), even when the first of the three specimens was smear negative. In addition, when compared with serial smears, the first-sputum NAA had a higher sensitivity (0.87; 95% confidence interval [CI], 0.74-0.95) and specificity (1.0) in the detection of subjects with positive M. tuberculosis cultures (smear sensitivity, 0.76; 95% CI, 0.61-0.87; and specificity, 0.96; 95% CI, 0.94-0.98). Conclusions: A single first-sputum NAA testing can rapidly and accurately identify the subset of patients with suspected TB who require RI according to serial sputum smears. Its potential use to shorten RI time does not preclude the need to obtain subsequent specimens for culture.

KW - Diagnostic test

KW - Nucleic acid amplification

KW - Sensitivity

KW - Specificity

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=48249154962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249154962&partnerID=8YFLogxK

U2 - 10.1164/rccm.200803-381OC

DO - 10.1164/rccm.200803-381OC

M3 - Article

VL - 178

SP - 300

EP - 305

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -